Ovarian cancer care is evolving, but for many patients, it can still feel confusing and overwhelming. New approaches like PARP inhibitors, antibody-drug conjugates, targeted therapies, and smarter use of surgery and chemotherapy are changing how doctors think about treatment, recurrence, and long-term management.
In this one-hour live Q&A, Dr. Beth Karlan, a leading ovarian cancer expert, answers questions from patients about what an ovarian cancer diagnosis means today. She explains how treatment decisions are made at different stages of disease, how recent advances are shaping care in 2026 and beyond, and more.
Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses or recommends any products or services. Consult your physician regarding any treatment or therapy.
